Zhang Li-Xin, Li Chun-Hai, Sun Li-Ya, Wang Miao, Lu Hao-Jun
Departmert of Tumor Molecular Biology, Bejing North Taiping Hospital and Beyiing Institute of Basic Medical Sciences, Beijing 100039, China.
Sheng Wu Gong Cheng Xue Bao. 2003 May;19(3):337-42.
MUC1 mucin is a high molecular weight, type I transmembrane glycoprotein. High and aberrant expression of MUC1 is observed in various types of tumors, which make it an ideal target for tumor biotherapy as well as a biomarker for tumor diagnosis and prognosis. MUC1/Y is an isoform of MUC1 generated by alternative splicing. Specific expression of MUC1/Y in breast cancer as well as its involvement in tumor cell signal transduction have been reported. In order to purify peptides containing MUC1/Y-specific epitope in E. coli and prepare MUC1/Y-specific antibody, DNA fragment encoding the MUC1/Y-specific peptide was amplified by PCR using MUC1/Y full length cDNA as the template and cloned into fusion expression vector pGEX-2T, resulting pGEX-Y30. DNA sequencing was performed to confirm the correct amplification and orientation of the target sequence. Competent E. coli DH5alpha was transformed with pGEX-Y30 and the expression was induced for 4-5 hours in 0.2 mmol/L IPTG at 30 degrees C and 37 degrees C. Expressed proteins were released from the cells by ultrasonication or B-PER II reagent treatments. The fusion protein GST-Y30 were purified by affinity and anion exchange columns and identified by SDS-PAGE and Western-blotting. Polyclonal antibody was prepared by immunizing rabbits with the GST-Y30 protein for 4 times with intervals of 3 weeks and purified by GST column. Western blotting, ELISA and immunohistochemistry analysis were carried out using the purified antibody to confirm its MUC1/Y-binding capacity and specificity. The expressed fusion protein GST-Y30 is about 31 kD in size and represented about 20% of total cellular proteins. The majority of the GST-Y30 protein existed as soluble form when the induction was carried out at both 30 degrees C and 37 degrees C. After the two-step purification, the purity of GST-Y30 was about 94%. The titer of polyserum generated by GST-Y30 immunization was 1:320,000 by ELISA. The antiserum showed MUC1/Y specificity and can recognize MUC1/Y on MCF7 cell. The MUC1/Y-specific polyclonal antibody can be used for studying the role of MUC1/Y in carcinogenesis.
黏蛋白1(MUC1)是一种高分子量的I型跨膜糖蛋白。在各种类型的肿瘤中均观察到MUC1的高表达和异常表达,这使其成为肿瘤生物治疗的理想靶点以及肿瘤诊断和预后的生物标志物。MUC1/Y是通过可变剪接产生的MUC1同种型。已有报道MUC1/Y在乳腺癌中的特异性表达及其参与肿瘤细胞信号转导的情况。为了在大肠杆菌中纯化含有MUC1/Y特异性表位的肽并制备MUC1/Y特异性抗体,以MUC1/Y全长cDNA为模板,通过PCR扩增编码MUC1/Y特异性肽的DNA片段,并将其克隆到融合表达载体pGEX-2T中,得到pGEX-Y30。进行DNA测序以确认目标序列的正确扩增和方向。用pGEX-Y30转化感受态大肠杆菌DH5α,并在30℃和37℃下于0.2 mmol/L异丙基-β-D-硫代半乳糖苷(IPTG)中诱导表达4 - 5小时。通过超声处理或B-PER II试剂处理从细胞中释放表达的蛋白质。融合蛋白GST-Y30通过亲和柱和阴离子交换柱进行纯化,并通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)和蛋白质免疫印迹法(Western-blotting)进行鉴定。用GST-Y30蛋白对兔子进行4次免疫,间隔3周,制备多克隆抗体,并通过GST柱进行纯化。使用纯化的抗体进行蛋白质免疫印迹法、酶联免疫吸附测定(ELISA)和免疫组织化学分析,以确认其与MUC1/Y的结合能力和特异性。表达的融合蛋白GST-Y30大小约为31 kDa,约占细胞总蛋白的20%。当在30℃和37℃下进行诱导时,大多数GST-Y30蛋白以可溶形式存在。经过两步纯化后,GST-Y30的纯度约为94%。通过ELISA测定,GST-Y30免疫产生的多抗血清效价为1:320,000。该抗血清显示出MUC1/Y特异性,能够识别MCF7细胞上的MUC1/Y。MUC1/Y特异性多克隆抗体可用于研究MUC1/Y在肿瘤发生中的作用。